Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zoe Arvanitakis

Showing results (121-130 of 131) with videos related to

Pageof 14
Sort By:
Molecular Neurodegeneration|February 3, 2025
Cellular senescence induced by cholesterol accumulation is mediated by lysosomal ABCA1 in APOE4 and ADShaowei Wang, Boyang Li, Jie Li, et al.
Parkinsonism & Related Disorders|January 2, 2007
Clinical-pathologic study of biomarkers in FTDP-17 (PPND family with N279K tau mutation)Zoe Arvanitakis, Robert J Witte, Dennis W Dickson, et al.
The Journal of Clinical Investigation|April 6, 2012
Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive declineKonrad Talbot, Hoau-Yan Wang, Hala Kazi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 25, 2025
Cardiovascular contributions to dementia: Examining sex differences and female-specific factorsMadeline Wood Alexander, Jane Paterson, Zoe Arvanitakis, et al.
Annals of Neurology|July 12, 2025
Sex Differences in Associations of Lewy Body Disease with Alzheimer's Disease and Cognitive DeclineMadeline Wood Alexander, D Luke Fischer, Lawren VandeVrede, et al.
Journal of Alzheimer'S Disease : JAD|October 7, 2017
Diabetes is Not Associated with Alzheimer's Disease NeuropathologyMaria Niures Pimentel Dos Santos Matioli, Claudia Kimie Suemoto, Roberta Diehl Rodriguez, et al.
Alzheimer'S & Dementia (New York, N. Y.)|August 12, 2024
Biological effects of sodium phenylbutyrate and taurursodiol in Alzheimer's diseaseSteven E Arnold, Suzanne Hendrix, Jessie Nicodemus-Johnson, et al.
Biorxiv : the Preprint Server for Biology|April 16, 2025
Evidence for cPLA2 activation in Alzheimer's Disease Synaptic PathologyQiu-Lan Ma, Brandon Ebright, Boyang Li, et al.
Acta Neuropathologica Communications|February 12, 2026
Evidence for cPLA2 activation in Alzheimer's disease synaptic pathologyQiu-Lan Ma, Brandon Ebright, Boyang Li, et al.
JAMA Neurology|November 10, 2025
Evaluation of Interventions for Cognitive Symptoms in Long COVID: A Randomized Clinical TrialDavid S Knopman, Deborah Koltai, Daniel T Laskowitz, et al.
Pageof 14

Showing results (121-130 of 131) with videos related to

Sort By:
Pageof 14
Molecular Neurodegeneration|February 3, 2025
Cellular senescence induced by cholesterol accumulation is mediated by lysosomal ABCA1 in APOE4 and ADShaowei Wang, Boyang Li, Jie Li, et al.
Parkinsonism & Related Disorders|January 2, 2007
Clinical-pathologic study of biomarkers in FTDP-17 (PPND family with N279K tau mutation)Zoe Arvanitakis, Robert J Witte, Dennis W Dickson, et al.
The Journal of Clinical Investigation|April 6, 2012
Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive declineKonrad Talbot, Hoau-Yan Wang, Hala Kazi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 25, 2025
Cardiovascular contributions to dementia: Examining sex differences and female-specific factorsMadeline Wood Alexander, Jane Paterson, Zoe Arvanitakis, et al.
Annals of Neurology|July 12, 2025
Sex Differences in Associations of Lewy Body Disease with Alzheimer's Disease and Cognitive DeclineMadeline Wood Alexander, D Luke Fischer, Lawren VandeVrede, et al.
Journal of Alzheimer'S Disease : JAD|October 7, 2017
Diabetes is Not Associated with Alzheimer's Disease NeuropathologyMaria Niures Pimentel Dos Santos Matioli, Claudia Kimie Suemoto, Roberta Diehl Rodriguez, et al.
Alzheimer'S & Dementia (New York, N. Y.)|August 12, 2024
Biological effects of sodium phenylbutyrate and taurursodiol in Alzheimer's diseaseSteven E Arnold, Suzanne Hendrix, Jessie Nicodemus-Johnson, et al.
Biorxiv : the Preprint Server for Biology|April 16, 2025
Evidence for cPLA2 activation in Alzheimer's Disease Synaptic PathologyQiu-Lan Ma, Brandon Ebright, Boyang Li, et al.
Acta Neuropathologica Communications|February 12, 2026
Evidence for cPLA2 activation in Alzheimer's disease synaptic pathologyQiu-Lan Ma, Brandon Ebright, Boyang Li, et al.
JAMA Neurology|November 10, 2025
Evaluation of Interventions for Cognitive Symptoms in Long COVID: A Randomized Clinical TrialDavid S Knopman, Deborah Koltai, Daniel T Laskowitz, et al.
Pageof 14